Report Two Adult Cases of High-grade Neuroepithelial Neoplasm Harbouring EP300::BCOR Fusions with Comprehensive Molecular Detection

Overview

Journal Brain Pathol

Date 2023 Jun 2

PMID 37265116

Authors

Yuqiao Xu

Yanghao Hou

Xiaohong Gao

Jing Li

Dezhi Jiang

Zengshan Li

Peizhen Hu

Yingmei Wang

Yuting Wen

Xiaohong Yao

Tao Luo

Qing Li

Zhenyu Ke

Junfeng Wu

Zhe Wang

Affiliations

Soon will be listed here.

Citing Articles

BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.

Ebrahimi A, Waha A, Schittenhelm J, Gohla G, Schuhmann M, Pietsch T Acta Neuropathol Commun. 2024; 12(1):60.

PMID: 38637838 PMC: 11025138. DOI: 10.1186/s40478-024-01780-5.

CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.

Barresi V, Cardoni A, Miele E, Pedace L, Masotto B, Nardini C Acta Neuropathol Commun. 2024; 12(1):8.

PMID: 38216991 PMC: 10785472. DOI: 10.1186/s40478-024-01726-x.

Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.

Nakata S, Arai Y, Fukuoka K, Shirakura T, Yamazaki A, Osawa S Brain Tumor Pathol. 2023; 41(1):35-39.

PMID: 38133797 DOI: 10.1007/s10014-023-00475-4.

References

Sturm D, Orr B, Toprak U, Hovestadt V, Jones D, Capper D . New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016; 164(5):1060-1072. PMC: 5139621. DOI: 10.1016/j.cell.2016.01.015. View

Torre M, Meredith D, Dubuc A, Solomon D, Perry A, Vasudevaraja V . Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. J Neuropathol Exp Neurol. 2019; 78(4):305-314. DOI: 10.1093/jnen/nlz011. View

de Lima L, Surme M, Gessi M, Mastronuzzi A, Miele E, Tamburrini G . Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews. Childs Nerv Syst. 2020; 36(8):1589-1599. DOI: 10.1007/s00381-020-04692-6. View

Jovanovic J, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G . Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood. 2007; 109(11):4635-40. DOI: 10.1182/blood-2006-10-050054. View

Ferris S, Velazquez Vega J, Aboian M, Lee J, Van Ziffle J, Onodera C . High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathol. 2019; 30(1):46-62. PMC: 6859193. DOI: 10.1111/bpa.12747. View

Tauziede-Espariat A, Pierron G, Siegfried A, Guillemot D, Uro-Coste E, Nicaise Y . The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication". Acta Neuropathol Commun. 2020; 8(1):178. PMC: 7607816. DOI: 10.1186/s40478-020-01064-8. View

Wu Z, Rajan S, Chung H, Raffeld M, Panneer Selvam P, Schweizer L . Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. Acta Neuropathol. 2022; 144(6):1175-1178. PMC: 10673683. DOI: 10.1007/s00401-022-02508-2. View

Capper D, Jones D, Sill M, Hovestadt V, Schrimpf D, Sturm D . DNA methylation-based classification of central nervous system tumours. Nature. 2018; 555(7697):469-474. PMC: 6093218. DOI: 10.1038/nature26000. View

Pisapia D, Ohara K, Bareja R, Wilkes D, Hissong E, Croyle J . Fusions involving BCOR and CREBBP are rare events in infiltrating glioma. Acta Neuropathol Commun. 2020; 8(1):80. PMC: 7271411. DOI: 10.1186/s40478-020-00951-4. View

10.

Lin D, Hemmerich A, Edgerly C, Duncan D, Severson E, Huang R . Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Gynecol Oncol. 2020; 157(2):357-366. DOI: 10.1016/j.ygyno.2020.02.024. View